Bioxytran Inc (BIXT)
0.1010
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Bioxytran Cash from Operations (TTM): -0.6641M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.6641M |
| December 31, 2023 | -0.7754M |
| September 30, 2023 | -0.8394M |
| June 30, 2023 | -1.216M |
| March 31, 2023 | -1.301M |
| December 31, 2022 | -1.806M |
| September 30, 2022 | -1.793M |
| June 30, 2022 | -1.218M |
| March 31, 2022 | -1.998M |
| December 31, 2021 | -1.697M |
| September 30, 2021 | -2.445M |
| June 30, 2021 | -2.312M |
| March 31, 2021 | -1.333M |
| December 31, 2020 | -1.099M |
| September 30, 2020 | -0.3938M |
| June 30, 2020 | -0.4141M |
| March 31, 2020 | -0.4481M |
| December 31, 2019 | -0.431M |
| September 30, 2019 | -0.4341M |
| June 30, 2019 | -0.3992M |
| March 31, 2019 | -0.3256M |
| December 31, 2018 | -0.1859M |
| September 30, 2018 | -0.0282M |
| June 30, 2018 | -0.0072M |
| March 31, 2018 | -0.0106M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0185M |
| September 30, 2017 | 0.0047M |
| June 30, 2017 | -0.0231M |
| March 31, 2017 | -0.0314M |
| December 31, 2016 | -0.0424M |
| September 30, 2016 | -0.0479M |
| June 30, 2016 | -0.0224M |
| March 31, 2016 | -0.0183M |
| December 31, 2015 | -0.0027M |
| September 30, 2015 | -0.0068M |
| June 30, 2015 | -0.0199M |
| March 31, 2015 | -0.0587M |
| December 31, 2014 | -0.0163M |
| September 30, 2014 | 0.0052M |
| June 30, 2014 | 0.0124M |
| March 31, 2014 | 0.0421M |
| December 31, 2013 | 0.0093M |
| September 30, 2013 | -0.0005M |
| June 30, 2013 | -0.0619M |
| March 31, 2013 | -0.0446M |
| December 31, 2012 | -0.0637M |
| September 30, 2012 | -0.2476M |
| June 30, 2012 | -0.2986M |
| March 31, 2012 | -0.3863M |
| December 31, 2011 | -0.3988M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-2.445M
Minimum
Sep 2021
-0.3938M
Maximum
Sep 2020
-1.151M
Average
-1.157M
Median
Cash from Operations (TTM) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -5.581M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |